Contribution By Pankaj Singh
Vitol has reportedly entered a partnership with WPU, a Denmark-based firm that recycles waste plastic into plastic oil.
The company will offtake and promote the recycled plastic oils produced by the new pyrolysis plant of WPU in Faarevejle which is
AstraZeneca plc has reportedly acquired a stake in Huma, a medical technology startup as part of a wider commercial collaboration between the two companies.
According to a credible source, the UK pharma giant has taken a nearly USD 33 million stake
FGX International, a leading marketer, and designer of non-prescription reading glasses have reportedly collaborated with Eastman, a global specialty materials firm. This move allows FGX to introduce sustainable and innovative eyewear frames to the m
An advisory committee of the Food and Drug Association (FDA) will hold a meeting next month regarding the future of COVID-19 booster doses in the U.S. and if it needs to be updated for specific variants.
The Vaccines and Related Biological Products
Rush Bowls, a Boulder, Colorado-based fast-casual concept famous for healthy meals in a bowl, has reportedly planned to open 50 new locations by the end of this year.
The brand intends to attain this objective through continued innovation and unveil
UK Prime Minister Boris Johnson will reportedly chair a roundtable on ways to increase the nuclear power output of the country.
This move comes as the PM prepares to issue his energy security plan this month amid increasing prices. Johnson will hold
The Standard Bank of South Africa Limited has reportedly banned the funding for all new coal-fired and oil-fired plants as a part of its plans to attain net-zero emissions by 2050.
More financial service companies are establishing net-zero targets t
EoCell Inc. and Morrow Batteries AS have reportedly signed a Master Development Agreement to promote best-in-class prismatic battery for the automotive sector.
The partnership is expected to provide an industry-leading battery that can be generated
Ascletis Pharma Inc. has reportedly announced to expand its production of ritonavir oral tablets to nearly 530 million tablets yearly to fulfill the possible escalation in the global and domestic demands.
The pharma company has implemented several m